Taurodeoxycholic acid

Taurodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Taurodeoxycholic acid is associated with abnormalities such as Ischemia and Wiskott-Aldrich Syndrome. The involved functions are known as Cell Proliferation, Transcriptional Activation, Phosphorylation, Anabolism and Biochemical Pathway. Taurodeoxycholic acid often locates in Body tissue, Epithelium, Blood, Mucous Membrane and Hepatic. The associated genes with Taurodeoxycholic acid are NOX5 gene, GPBAR1 gene, NR1H4 gene and SLC33A1 gene. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid.

Cross Reference

Introduction

To understand associated biological information of Taurodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Taurodeoxycholic acid?

Taurodeoxycholic acid is suspected in Ischemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Taurodeoxycholic acid

MeSH term MeSH ID Detail
Tay-Sachs Disease D013661 2 associated lipids
Short Bowel Syndrome D012778 3 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Fetal Resorption D005327 15 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Cholestasis D002779 23 associated lipids
Birth Weight D001724 23 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with Taurodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Taurodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Taurodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Taurodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Taurodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Taurodeoxycholic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Taurodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 449
Authors Title Published Journal PubMed Link
García-Arnandis I et al. Control of cell migration and inflammatory mediators production by CORM-2 in osteoarthritic synoviocytes. 2011 PLoS ONE pmid:21961038
Trottier J et al. Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. 2011 PLoS ONE pmid:21760958
Dai J et al. Impact of bile acids on the growth of human cholangiocarcinoma via FXR. 2011 J Hematol Oncol pmid:21988803
Halin J and Mattjus P Effects of bile salts on glucosylceramide containing membranes. 2011 Biochim. Biophys. Acta pmid:21910967
Lunelli M et al. Crystal structure of PrgI-SipD: insight into a secretion competent state of the type three secretion system needle tip and its interaction with host ligands. 2011 PLoS Pathog. pmid:21829362
Zahiri HR et al. Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury. 2011 Surgery pmid:21878234
Martin NA et al. Active transport of bile acids decreases mucin 2 in neonatal ileum: implications for development of necrotizing enterocolitis. 2011 PLoS ONE pmid:22162748
Ngamukote S et al. Cholesterol-lowering activity of the major polyphenols in grape seed. 2011 Molecules pmid:21694670
Kaddurah-Daouk R et al. Enteric microbiome metabolites correlate with response to simvastatin treatment. 2011 PLoS ONE pmid:22022402
Zhang Y et al. Loss of organic anion transporting polypeptide 1a1 increases deoxycholic acid absorption in mice by increasing intestinal permeability. 2011 Toxicol. Sci. pmid:21914718